Abstract
Coronary artery disease remains a major hazard within the western world despite early revascularisation and advanced medical therapy strategies. One of its major substrates is platelet activation and thrombus formation, triggering acute events such as myocardial infarction and ischemic strokes. There are a variety of non-invasive imaging strategies being translated from bench to bedside into clinical practice that tackle specific aspects of the pathophysiology of thrombus formation. Some of those techniques are able to visualize native contrast differences between thrombus and surrounding tissue, others focus on the use of specific contrast agents targeting thrombotic components such as fibrin or activated platelets. Some of those techniques are still in the pre-clinical stage; others have already entered the clinical arena. The current review article will introduce different techniques and their stage of development on their way from bench to bedside with a specific focus on cardiac magnetic resonance imaging, that has evolved over the last years providing high quality information on anatomy, perfusion and myocardial tissue characteristics such as scarring in clinical practice. Finally, we will give an outlook on how this exciting field might evolve in the future.
Keywords: Cardiac magnetic resonance imaging, non-invasive imaging, atherosclerosis, coronary artery disease, platelets, vulnerable plaque, myocardial infarction, stroke, SPECT, low-density lipoprotein
Current Vascular Pharmacology
Title:Platelets in Cardiovascular Imaging
Volume: 10 Issue: 5
Author(s): Andreas Schuster, Marcus R. Makowski, Christian H.P. Jansen, Meinrad Gawaz, Rene M. Botnar, Eike Nagel and Boris Bigalke
Affiliation:
Keywords: Cardiac magnetic resonance imaging, non-invasive imaging, atherosclerosis, coronary artery disease, platelets, vulnerable plaque, myocardial infarction, stroke, SPECT, low-density lipoprotein
Abstract: Coronary artery disease remains a major hazard within the western world despite early revascularisation and advanced medical therapy strategies. One of its major substrates is platelet activation and thrombus formation, triggering acute events such as myocardial infarction and ischemic strokes. There are a variety of non-invasive imaging strategies being translated from bench to bedside into clinical practice that tackle specific aspects of the pathophysiology of thrombus formation. Some of those techniques are able to visualize native contrast differences between thrombus and surrounding tissue, others focus on the use of specific contrast agents targeting thrombotic components such as fibrin or activated platelets. Some of those techniques are still in the pre-clinical stage; others have already entered the clinical arena. The current review article will introduce different techniques and their stage of development on their way from bench to bedside with a specific focus on cardiac magnetic resonance imaging, that has evolved over the last years providing high quality information on anatomy, perfusion and myocardial tissue characteristics such as scarring in clinical practice. Finally, we will give an outlook on how this exciting field might evolve in the future.
Export Options
About this article
Cite this article as:
Schuster Andreas, R. Makowski Marcus, H.P. Jansen Christian, Gawaz Meinrad, M. Botnar Rene, Nagel Eike and Bigalke Boris, Platelets in Cardiovascular Imaging, Current Vascular Pharmacology 2012; 10 (5) . https://dx.doi.org/10.2174/157016112801784620
DOI https://dx.doi.org/10.2174/157016112801784620 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Regulation of GABA Neurotransmission by Glutamic Acid Decarboxylase (GAD)
Current Pharmaceutical Design Current Trends in the Animal Models for Screening of Nootropic Agents: A Systematic Review
Current Reviews in Clinical and Experimental Pharmacology New Alternative Anticoagulants in Atrial Fibrillation: The Move Beyond Warfarin.
Reviews on Recent Clinical Trials The Interface Between Alzheimers Disease, Normal Aging, and Related Disorders
Current Aging Science Post-Wortmannin Era: Novel Phosphoinositide 3-Kinase Inhibitors with Potential Therapeutic Applications
Current Enzyme Inhibition Effects of Ranolazine on Cardiovascular System
Recent Patents on Cardiovascular Drug Discovery Brain Network Connectivity Mediates Education-related Cognitive Performance in Healthy Elderly Adults
Current Alzheimer Research Editorial
Current Medical Imaging Vitamin D and Depression: The Evidence from an Indirect Clue to Treatment Strategy
Current Drug Targets Potential Protective Effects of Cannabidiol on Neuroanatomical Alterations in Cannabis Users and Psychosis: A Critical Review
Current Pharmaceutical Design Impacts of Nanoparticles on Cardiovascular Diseases: Modulating Metabolism and Function of Endothelial Cells
Current Drug Metabolism How to Recognize Epicardial Origin of Ventricular Tachycardias?
Current Cardiology Reviews Tissue Engineering Techniques in Cardiac Repair and Disease Modelling
Current Pharmaceutical Design Estrogen, Neuroprotection and Neurogenesis after Ischemic Stroke
Current Drug Targets The Effect of Positive Mental Imagery on Labor Pain Tolerance in Primiparous Women Referred to Atieh Hospital of Hamadan, Iran, 2018: A Randomized Controlled Clinical Trial Study
Current Women`s Health Reviews Anti-Shock Garments for Obstetric Hemorrhage
Current Women`s Health Reviews Molecular Probes for Malignant Melanoma Imaging
Current Pharmaceutical Biotechnology Empyema and Bronchopleural Fistula Following Lung Resection
Current Respiratory Medicine Reviews Pharmacological Activity of Cardiovascular Agents from Herbal Medicine
Cardiovascular & Hematological Agents in Medicinal Chemistry P Wave Morphology in Guiding the Ablation Strategy of Focal Atrial Tachycardias and Atrial Flutter
Current Cardiology Reviews